相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study
Aliza Hussain et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2022)
Lipoprotein Lipase and Its Regulators: An Unfolding Story
Shuangcheng Alivia Wu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2021)
Novel therapies for familial hypercholesterolemia
Farzahna Mohamed et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2021)
The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage
Najia Jin et al.
ACS CHEMICAL BIOLOGY (2021)
ANGPTL3 Inhibition With Evinacumab Results in Faster Clearance of IDL and LDL apoB in Patients With Homozygous Familial Hypercholesterolemia-Brief Report
Laurens F. Reeskamp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Advances in biological therapies for dyslipidemias and atherosclerosis
Eftaxia-Konstantina Valanti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2021)
FDA approves first anti-ANGPTL3 antibody, for rare cardiovascular indication
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2021)
Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3
Min Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B
Nick S. Nurmohamed et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Global epidemiology of dyslipidaemias
Angela Pirillo et al.
NATURE REVIEWS CARDIOLOGY (2021)
ANGPTL3 gene variants in subjects with familial combined hyperlipidemia
A. M. Bea et al.
SCIENTIFIC REPORTS (2021)
ApoA5 lowers triglyceride levels via suppression of ANGPTL3/8-mediated LPL inhibition
Yan Q. Chen et al.
JOURNAL OF LIPID RESEARCH (2021)
Triglyceride lowering 2.0: back to the future?
Chris J. Packard
EUROPEAN HEART JOURNAL (2020)
Remnant cholesterol, coronary atheroma progression and clinical events in statin-treated patients with coronary artery disease
Mohamed B. Elshazly et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice[S]
Marianne G. Pouwer et al.
JOURNAL OF LIPID RESEARCH (2020)
ANGPTL3, PCSK9, and statin therapy drive remarkable reductions in hyperlipidemia and atherosclerosis in a mouse model
Eva Hurt-Camejo
JOURNAL OF LIPID RESEARCH (2020)
Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi[S]
Andrew A. Butler et al.
JOURNAL OF LIPID RESEARCH (2020)
Long-Term Evolocumab in Patients With Familial Hypercholesterolemia
Raul D. Santos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
Massimiliano Ruscica et al.
PHARMACOLOGICAL RESEARCH (2020)
The Clinical Role of Angiopoietin-Like Protein 3 in Evaluating Coronary Artery Disease in Patients with Obstructive Sleep Apnea
Juan Li et al.
CARDIOVASCULAR DRUGS AND THERAPY (2020)
Familial Hypercholesterolemia and Atherosclerosis: Animal Models and Therapeutic Advances
Suowen Xu et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
High-Serum Angiopoietin-Like Protein 3 Levels Associated with Cardiovascular Outcome in Patients with Coronary Artery Disease
Ming-Chun Chen et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2020)
Lipid lowering therapy in cardiovascular disease: From myth to molecular reality
Philipp Mourikis et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance
Rene C. Adam et al.
JOURNAL OF LIPID RESEARCH (2020)
Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids
Yan Q. Chen et al.
JOURNAL OF LIPID RESEARCH (2020)
A randomized study investigating the safety, tolerability, and pharmacokinetics of evinacumab, an ANGPTL3 inhibitor, in healthy Japanese and Caucasian subjects
Mariko Harada-Shiba et al.
ATHEROSCLEROSIS (2020)
LDL-Cholesterol Reduction by ANGPTL3 Inhibition in Mice Is Dependent on Endothelial Lipase
Liya Wu et al.
CIRCULATION RESEARCH (2020)
Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
Daniel Gaudet et al.
EUROPEAN HEART JOURNAL (2020)
Evinacumab for Homozygous Familial Hypercholesterolemia
Frederick J. Raal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Evinacumab in Patients with Refractory Hypercholesterolemia
Robert S. Rosenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Serum angiopoietin-like 3 levels are elevated in obese non diabetic men but are unaffected during an oral glucose tolerance test
Maria Fernanda Garces et al.
SCIENTIFIC REPORTS (2020)
The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation
Mohamed Abu-Farha et al.
PROGRESS IN LIPID RESEARCH (2020)
Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State
Emmi Tikkanen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Harnessing nucleic acid-based therapeutics for atherosclerotic cardiovascular disease: state of the art
Fatemeh Vandat Lasemi et al.
DRUG DISCOVERY TODAY (2019)
The next generation of CRISPR-Cas technologies and applications
Adrian Pickar-Oliver et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial
Sabina A. Murphy et al.
JAMA CARDIOLOGY (2019)
Circulating Angptl3 and Angptl8 Are Increased in Patients with Hypothyroidism
Longyan Yang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
Zahid Ahmad et al.
CIRCULATION (2019)
Association Between Triglyceride Lowering and Reduction of Cardiovascular Risk Across Multiple Lipid-Lowering Therapeutic Classes A Systematic Review and Meta-Regression Analysis of Randomized Controlled Trials
Nicholas A. Marston et al.
CIRCULATION (2019)
Atherosclerosis
Peter Libby et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Functional Analysis of LDLR (Low-Density Lipoprotein Receptor) Variants in Patient Lymphocytes to Assess the Effect of Evinacumab in Homozygous Familial Hypercholesterolemia Patients With a Spectrum of LDLR Activity
Poulabi Banerjee et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Lipid Management for the Prevention of Atherosclerotic Cardiovascular Disease
Erin D. Michos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Antibodies to watch in 2019
Helene Kaplon et al.
MABS (2019)
Angiopoietin-Like 3 From Discovery to Therapeutic Gene Editing
Xiao Wang et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
New medications targeting triglyceride-rich lipoproteins: Can inhibition of ANGPTL3 or apoC-III reduce the residual cardiovascular risk?
Vesa M. Olkkonen et al.
ATHEROSCLEROSIS (2018)
Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol
Yu-Xin Xu et al.
ATHEROSCLEROSIS (2018)
Reduced Blood Lipid Levels With In Vivo CRISPR-Cas9 Base Editing of ANGPTL3
Alexandra C. Chadwick et al.
CIRCULATION (2018)
Heart Disease and Stroke Statistics-2018 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2018)
DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke
Wei-Jun Li et al.
LIPIDS IN HEALTH AND DISEASE (2018)
New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases
Xin Su et al.
LIPIDS IN HEALTH AND DISEASE (2018)
In vivo genome editing of ANGPTL3: a therapy for atherosclerosis?
June-Wha Rhee et al.
NATURE REVIEWS CARDIOLOGY (2018)
Association of circulating ANGPTL 3, 4, and 8 levels with medical status in a population undergoing routine medical checkups: A cross-sectional study
Jun Morinaga et al.
PLOS ONE (2018)
CRISPR-Cas guides the future of genetic engineering
Gavin J. Knott et al.
SCIENCE (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
Maria Giovanna Lupo et al.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2018)
PCSK9 Inhibitors Economics and Policy
Mark A. Hlatky et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
Nathan O. Stitziel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Genetics: ANGPTL3 deficiency protects from CAD
Irene Fernández-Ruiz
Nature Reviews Cardiology (2017)
Angiopoietin-like 3 in lipoprotein metabolism
Sander Kersten
NATURE REVIEWS ENDOCRINOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
Mark J. Graham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease
F. E. Dewey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular Mechanisms of Antisense Oligonucleotides
Stanley T. Crooke
NUCLEIC ACID THERAPEUTICS (2017)
Post-GWAS methodologies for localisation of functional non-coding variants: ANGPTL3
Federico Oldoni et al.
ATHEROSCLEROSIS (2016)
Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents
Sumeet A. Khetarpal et al.
CELL METABOLISM (2016)
Clinical and genetic analysis of a family diagnosed with familial hypobetalipoproteinemia in which the proband was diagnosed with diabetes mellitus
Xiaoli Wang et al.
ATHEROSCLEROSIS (2015)
Regulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin
P. A. Nidhina Haridas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion
Yan Wang et al.
JOURNAL OF LIPID RESEARCH (2015)
ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys
Viktoria Gusarova et al.
JOURNAL OF LIPID RESEARCH (2015)
Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial
Frederick J. Raal et al.
LANCET (2015)
Effects of Regular Recreational Exercise Training on Serum ANGPTL3-Like Protein and Lipid Profile in Young Healthy Adults
Ewa Smol et al.
JOURNAL OF HUMAN KINETICS (2015)
Differential Association of Plasma Angiopoietin-Like Proteins 3 and 4 With Lipid and Metabolic Traits
Nidhi Mehta et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1α activity
Pelagia Foka et al.
JOURNAL OF HEPATOLOGY (2014)
Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
Anders Berg Jorgensen et al.
EUROPEAN HEART JOURNAL (2013)
MicroRNA-27b Is a Regulatory Hub in Lipid Metabolism and Is Altered in Dyslipidemia
Kasey C. Vickers et al.
HEPATOLOGY (2013)
Common genetic variants associated with lipid profiles in a Chinese pediatric population
Yue Shen et al.
HUMAN GENETICS (2013)
Common variants associated with plasma triglycerides and risk for coronary artery disease
Ron Do et al.
NATURE GENETICS (2013)
Serum Lipids and Lipoproteins in Chinese Men and Women
Wenying Yang et al.
CIRCULATION (2012)
Characterization of Three Kindreds With Familial Combined Hypolipidemia Caused by Loss-of-Function Mutations of ANGPTL3
Livia Pisciotta et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Angiopoietin-like protein 3 supports the activity of hematopoietic stem cells in the bone marrow niche
Junke Zheng et al.
BLOOD (2011)
O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 POSSIBLE ROLE OF POLYPEPTIDE GalNAc-TRANSFERASE-2 IN REGULATION OF CONCENTRATIONS OF PLASMA LIPIDS
Katrine T. -B. G. Schjoldager et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Angiopoietin-like Protein 3 Inhibits Lipoprotein Lipase Activity through Enhancing Its Cleavage by Proprotein Convertases
Jun Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample
Marius R. Robciuc et al.
JOURNAL OF LIPID RESEARCH (2010)
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich et al.
NATURE (2010)
Exome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia
Kiran Musunuru et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)
E-Chiang Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glycoproteomics Analysis of Human Liver Tissue by Combination of Multiple Enzyme Digestion and Hydrazide Chemistry
Rui Chen et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
Cristen J. Willer et al.
NATURE GENETICS (2008)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Sekar Kathiresan et al.
NATURE GENETICS (2008)
Hepatic proprotein convertases modulate HDL metabolism
Weijun Jin et al.
CELL METABOLISM (2007)
Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase
Mitsuru Shimamura et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects
Sawako Hatsuda et al.
JOURNAL OF VASCULAR RESEARCH (2007)
The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone
C Fugier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells
CC Zhang et al.
NATURE MEDICINE (2006)
Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry
T Liu et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Transgenic angiopoietin-like (Angptl)4 overexpression and targeted disruption of Angptl4 and Angptl3:: Regulation of triglyceride metabolism
A Köster et al.
ENDOCRINOLOGY (2005)
Differential regulation and properties of angiopoietin-like proteins 3 and 4
HF Ge et al.
JOURNAL OF LIPID RESEARCH (2005)
Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor
M Shimamura et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Locating Ath8, a locus for murine atherosclerosis susceptibility and testing several of its candidate genes in mice and humans
R Korstanje et al.
ATHEROSCLEROSIS (2004)
ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states
K Inukai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3) -: ANGPTL3 is cleaved and activated in vivo
M Ono et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A decreased expression of angiopoietin-like 3 is protective against atherosclerosis in apoE-deficient mice
Y Ando et al.
JOURNAL OF LIPID RESEARCH (2003)
ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase
T Shimizugawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
ANGPTL3 stimulates endothelial cell adhesion and migration via integrin αvβ3 and induces blood vessel formation in vivo
G Camenisch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Angptl3 regulates lipid metabolism in mice
R Koishi et al.
NATURE GENETICS (2002)
Regulation of lipoprotein lipase by the oxysterol receptors, LXRα and LXRβ
Y Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
